Celldex Therapeutics, Inc. — Director's Dealing 2014

Dec 19, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2014-12-17

Reporting Person: van den Broek Richard (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.001 per share	200000	Indirect
Common stock, par value $0.001 per share	15000	Indirect

Footnotes

F1: These shares are held through a wholly-owned limited liability company, HSMR Advisors, LLC.